Press release
Lupus Therapeutics Market Analysis By Disease Type, By Treatment Type, By Route of Administration, By End User & Forecast 2023-2032
Lupus Therapeutics Market
The increasing prevalence of lupus disorders across the globe is one of the most important driving factors, impelling the growth in the global lupus therapeutics market. Moreover, the growing amount of investments, intended at developing high end and technically enabled healthcare arrangement and facilities in numerous developed as well as developing nations is also projected to foster the growth and development within the global lupus therapeutics market in upcoming years. The growing number of research and drug development and drug discovery projects under taken by the market players are also affecting the growth in the global lupus therapeutics market. However, the risk of adverse side effects caused by the medications and therapeutics in the global lupus therapeutics market may limit the industry's growth in near future.
Click Here to Access the Free Sample Report @ https://analyticsmarketresearch.com/sample-request/lupus-therapeutics-market/57608/
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus) was first reported from Wuhan, China in December 2019, and was stated as a global pandemic by the World Health Organization (WHO), which designates this SARS-CoV-2 infection as novel Coronavirus (COVID-19). As per the Coronavirus (COVID-19), Weekly Epidemiological Update by the World Health Organization, COVID-19 has spread across the world infecting over 409 million population reaching to more than 5.8 million deaths as of February 13, 2022. The negative impact of COVID-19 on the healthcare sector is massive and it has considerably disturbed the healthcare industries' complete supply chain, from raw materials to manufacturing and delivery. Likewise, the COVID-19 pandemic is expected to show a positive impact on the overall growth of the lupus therapeutics market owing to the association of COVID-19 with lupus. For instance, as per an article published by the Journal of Medical Case Reports in January 2021, connotation between COVID-19 and lupus is not yet determined but it recommends that COVID-19 could be a possible agent which is accountable for producing autoantibodies and causing systemic lupus erythematosus. There has been the first case of SLE manifestation following COVID-19 of a 39-year-old male in Iran reported by the same source.
Disease Type Insights
The systemic lupus erythematosus (SLE) segment led the market for lupus therapeutics and accounted for the largest revenue share of around 30% in 2021. Systemic lupus erythematosus is the most prevalent type of lupus that causes harm to several organs across the body such as the lungs, kidney, heart, and others. Systemic lupus erythematosus causes inflammation in the skin, lungs, joints, blood cells, kidneys, etc. This condition usually goes over cycles of flare-ups (symptoms appear) and remissions (symptoms disappear).
Route of Administration Insights
On the basis of route of administration, the market is segmented into oral, subcutaneous, intravenous and others. In 2021, the oral segment ruled the market for lupus therapeutics and held the largest market share of 38%. The oral segment is made up of small molecule drugs, which are considered the mainstream treatment for Lupus, and they are also simply managed. However, the second-largest share of the market was held by the intravenous segment in the forecasted year.
Region Insights
North America market dominated the global lupus therapeutics market in terms of demand and industry share. This trend can be accredited due to the existence of high number of important industry players as well as the presence of highly sophisticated and well-trenched medical and healthcare substructure in the region. Moreover, the increasing incidence of lupus disorders and developments in the diagnosis boost the growth of the lupus therapeutics market in this region. Furthermore, estimated approvals of new drugs and strong diagnosis plans for lupus will also contribute to the growth of the market in the Americas.
However, Asia-Pacific is anticipated to grow during the forecasted period owing to number of population and growing healthcare expenditure in this region.
Key Companies Insights
The market for lupus therapeutics is moderately competitive. With the rising applications of lupus therapeutics, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the lupus therapeutics market, ultimately boosting the market growth.
Some of the key companies working in the global lupus therapeutics market include:
• Hikma Pharmaceuticals PLC
• Lupus Therapeutics
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc
• Amgen Inc.
• Novartis AG
• Sanofi
• UCB S.A.
• ImmuPharma PLC
• Bayer AG
• Merck & Co., Inc.
• Aurinia Pharmaceuticals Inc.
• Pfizer Inc.
• ADMA Biologics, Inc.
• AstraZeneca
• F. Hoffmann-La Roche Ltd
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International Gmbh
• Other players
Purchase This Premium Report Now @ https://analyticsmarketresearch.com/purchase/lupus-therapeutics-market/57608/?license=single
Some of the Recent Developments:
• In December 2020, GlaxoSmithKline plc received the U.S. Food and Drug Administration (FDA) approval for its drug BENLYSTA (belimumab) to be used along with standard therapy for treatment of adult patients with active lupus nephritis (LN), a kidney disease caused due to SLE.
• In December 2017, Immupharma plc. developed a drug Lupozor that completed the phase 3 clinical study after receiving fast-track designation from the US Food and Drug Administration.
Segments
By Disease Type
• Systemic Lupus Erythematosus (SLE)
• Cutaneous Lupus Erythematosus
• Drug-Induced Lupus Erythematosus
• Neonatal Lupus
By Treatment Type
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Biologics
• Antimalarial Drugs
• Corticosteroids
• Others
By Route of Administration
• Oral
• Subcutaneous
• Intravenous
• Others
By End User
• Hospitals & Clinics
• Diagnostic Laboratories
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Read Full Research Report @ https://analyticsmarketresearch.com/reports/lupus-therapeutics-market/57608/
Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Website: https://analyticsmarketresearch.com/contactus/
About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Therapeutics Market Analysis By Disease Type, By Treatment Type, By Route of Administration, By End User & Forecast 2023-2032 here
News-ID: 2927320 • Views: …
More Releases from Analytics Market Research
Global Texture Paint Market Rising Trends, Technology Research and Advancement O …
The Global Texture Paint Market size was valued at USD 12,400 million in 2022 and is projected to reach USD 16,700 million by 2033, growing at a CAGR of 4.5% during the forecast period.
The texture paint market refers to the industry involved in the production, distribution, and sale of texture paints. Texture paints are specialized coatings used to add texture and visual interest to surfaces, such as walls, ceilings, furniture,…
Guarding the Global Flow: Exploring the Growth Potential and Security Innovation …
The global Supply Chain Security Market size was valued at USD 2.56 billion in 2022, and is projected to reach USD 3.57 billion by 2032 at a CAGR of 11.5% from 2023 to 2032.
The supply chain security market refers to the set of solutions and services aimed at securing the flow of goods, services, and information across the global supply chain. The primary objective of supply chain security is to…
Clouding the Future: Unveiling the Global Public Cloud Market's Transformation a …
The global public cloud market was estimated at USD 211.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2032. Rapid progress of digital transformation in the industry, prevalence of internet and mobile devices, and increasing consumption of big data are the major drivers of market growth.
Developing next-generation industrial solutions is leveraging the cloud and requires a platform that…
Revolutionizing Education: Exploring the Global Learning Management System Marke …
The global Learning Management System Market size was valued at USD 27.56 billion in 2022, and is projected to reach USD 62.57 billion by 2032 at a CAGR of 18.5% from 2023 to 2032.
A Learning Management System (LMS) is a software application designed to manage and deliver educational and training courses, resources, and assessments to learners. It is used by educational institutions, businesses, and organizations to create and deliver courses,…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
